A rose by any other...

Pharmacy Daily - - News -

“A ROSE by any other name would smell as sweet”, said Wil­liam Shake­speare’s Juliet, but a drug name pro­nounced dif­fer­ently may not, ac­cord­ing to an editorial in this months’s edi­tion of Aus­tralian Pre­scriber, the of­fi­cial organ of NPS MedicineWise.

For­mer edi­tor of NPS RADAR Craig Pat­ter­son high­lights the chal­lenges fac­ing dis­pensers and clin­i­cians try­ing to pro­nounce some new drugs such as xek­izumab, roval­pituzumab, to­fac­i­tinib and ide­lal­isib.

“The prob­lem of looka­like and sounda­like drug and brand names is well recog­nised, but there is an ev­i­dence gap re­gard­ing any im­pact that mis­pro­nun­ci­a­tion may have on pa­tient safety,” Pat­ter­son wrote.

Tele­phone or­ders be­tween pre­scribers, clin­i­cal han­dovers, voice-recog­ni­tion soft­ware and text-to-speech sys­tems are all part of the prob­lem - see the three­minute read at nps.org.au.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.